Having a strong in-line portfolio and promising asset mix within one’s developmental pipeline is insufficient in today’s competitive biopharmaceutical universe. Biopharmaceutical companies are increasingly relying on competitive insights and intelligence gleaned from the field and the overall importance of this cannot be overlooked. Field-based “competitive intelligence” is often times unreliable, inaccurate and deemed ultimately hearsay.
Whereas internally developed CI leads to many “red herrings” and unfounded rumors, engaging with Molekule Consulting leads you down a path of accuracy and timeliness. We develop evidence-based clinical, commercial, manufacturing and supply chain & logistics and regulatory intelligence founded on pragmatic and triangulated primary human source interviews.
Molekule leverages a rigorous, methodical and iterative primary research methodology to deriving accurate, precise, innovative, and useful competitive intelligence. By collecting the information that matters to our client partners, refining it through our proprietary rigorous analysis process, and transforming raw competitive information and data into actionable competitive intelligence, Molekule empowers our client partners to surpass the competition and evade competitive “blind spots” and “pinch points.”
LEARN MORE ABOUT THE MOLEKULE APPROACH